- Companies
- Autonomix Medical
Autonomix Medical Valuation Multiples
Autonomix Medical is valued at $8M as of October 2026. In the last fiscal year, Autonomix Medical EBITDA was ($17M).
Autonomix Medical Overview
About Autonomix Medical
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
Founded
2014
HQ
Employees
11
Website
Financials (Last FY)
EV
$4M
Valuation Multiples
Start free trialAutonomix Medical Financials
Autonomix Medical reported last fiscal year revenue of - and negative EBITDA of ($17M).
In the same fiscal year, Autonomix Medical generated - in gross profit, ($17M) in EBITDA losses, and had net loss of ($17M).
Revenue (LTM)
Autonomix Medical P&L
In the most recent fiscal year, Autonomix Medical reported revenue of - and EBITDA of ($17M).
Autonomix Medical is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.
Financial data powered by Morningstar, Inc.
Autonomix Medical Stock Performance
Autonomix Medical has current market cap of $8M, and enterprise value of $4M.
Market Cap Evolution
Autonomix Medical's stock price is $3.92.
Autonomix Medical share price increased by 1.8% in the last 30 days.
Autonomix Medical has an EPS (earnings per share) of $-8.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4M | $8M | 1.8% | 1.8% | - | - | $-8.53 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAutonomix Medical Valuation Multiples
Autonomix Medical trades at (0.2x) EV/EBITDA.
Autonomix Medical Financial Valuation Multiples
As of October 2, 2026, Autonomix Medical has market cap of $8M and EV of $4M.
Autonomix Medical has a P/E ratio of (0.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Autonomix Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Autonomix Medical Margins & Growth Rates
Autonomix Medical decreased net profit by 16% in the last fiscal year.
Autonomix Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Autonomix Medical Operational KPIs
Autonomix Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.5M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Autonomix Medical Competitors
Autonomix Medical competitors include Modne Zakupy, Ensysce Biosciences, Co-Diagnostics, Icecure Medical, Work Medical Technology Group, Scandinavian ChemoTech, Lucyd, Droneacharya Aerial, SUPA Consolidated and Sds Optic.
Most Autonomix Medical public comparables operate across Medical Devices, Autonomous Tech, BioTech and DeepTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1K | ($72K) | 8212.4x | - | (106.7x) | - | |||
| - | ($10M) | - | 1.5x | (0.7x) | - | |||
| $622K | ($48M) | 9.1x | 8.8x | (0.1x) | - | |||
| $3M | ($15M) | - | - | - | - | |||
| $10M | $163K | 1.4x | - | 83.4x | - | |||
| $1M | ($449K) | 6.0x | 4.7x | (16.3x) | (24.1x) | |||
| $3M | ($7M) | 1.6x | 1.6x | (0.6x) | (0.5x) | |||
| $2M | $727K | 5.3x | - | 11.1x | - | |||
This data is available for Pro users. Sign up to see all Autonomix Medical competitors and their valuation data. Start Free Trial | ||||||||
Autonomix Medical VC Funding History
Before going public, Autonomix Medical raised $9M in total equity funding, across 4 rounds.
Autonomix Medical Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Autonomix Medical
| When was Autonomix Medical founded? | Autonomix Medical was founded in 2014. |
| Where is Autonomix Medical headquartered? | Autonomix Medical is headquartered in United States. |
| How many employees does Autonomix Medical have? | As of today, Autonomix Medical has over 11 employees. |
| Is Autonomix Medical publicly listed? | Yes, Autonomix Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Autonomix Medical? | Autonomix Medical trades under AMIX ticker. |
| When did Autonomix Medical go public? | Autonomix Medical went public in 2024. |
| Who are competitors of Autonomix Medical? | Autonomix Medical main competitors include Modne Zakupy, Ensysce Biosciences, Co-Diagnostics, Icecure Medical, Work Medical Technology Group, Scandinavian ChemoTech, Lucyd, Droneacharya Aerial, SUPA Consolidated, Sds Optic. |
| What is the current market cap of Autonomix Medical? | Autonomix Medical's current market cap is $8M. |
| Is Autonomix Medical profitable? | No, Autonomix Medical is not profitable. |
| What is the current net income of Autonomix Medical? | Autonomix Medical's last 12 months net income is ($16M). |
| How many companies Autonomix Medical has acquired to date? | Autonomix Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Autonomix Medical has invested to date? | Autonomix Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Autonomix Medical
Lists including Autonomix Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




